Connect with MMS
MMS is the leading data-focused CRO dedicated to supporting your needs. To request more information or to speak with a representative from MMS, please use this form and one of our colleagues will contact you shortly.
Rajajinagar
Bangalore 560010, India
Scottish Provident Building,
7 Donegall Square West,
Belfast, BT1 6JH
United Kingdom
Heuwelsig 9332, Bloemfontein
South Africa
Suggested For You
perspectives
April 27th, 2026
From Stigma to Signal: The Executive Order, CNPV Vouchers, and What Comes Next for Psychedelics
perspectives
April 20th, 2026
The FDA Drug Shortage List Signals Deeper Concerns for the US Medicine Supply Chain
perspectives
April 15th, 2026
Decision-Making in Early-Phase Oncology Trials: Navigating Uncertainty with Evidence Frameworks
perspectives
April 8th, 2026
Four Pillars of My Success as a Clinical Trial Transparency Specialist
webinar
March 26th, 2026
Making the Right Decisions With Incomplete Evidence in Early-Phase Oncology Trials
perspectives
March 25th, 2026
REMS and Labeling Are Strategic Design Decisions, Not Late-Stage Add-Ons
perspectives
March 12th, 2026
AI in Pharma: Autopilot Is Not the Same as Removing the Pilot
webinar
April 30th, 2026
Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors
perspectives
March 3rd, 2026
Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design
perspectives
February 25th, 2026
Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency
perspectives
February 10th, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
news
February 5th, 2026
MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions